Impulse Monitoring Acquires the Assets of Great Lakes Intraoperative Neuromonitoring

Acquisition to expand IMI market share in western New York State

COLUMBIA, Md.--(BUSINESS WIRE)-- Impulse Monitoring, Inc. (IMI), a leading provider of intraoperative neurophysiologic monitoring (IONM) services to hospitals, today announced that it has acquired the assets of Great Lakes Intraoperative Monitoring, LP (GLIM), a subsidiary of Williamsville, NY-based Archer Medical Diagnostic Testing, Inc. Founded in 2004, GLIM currently provides IONM services to 14 hospitals in the western New York area, including Buffalo and Rochester. Terms of the acquisition were not disclosed.

IONM assesses neurological function involving the brain, spinal cord and related nerve structures during such surgeries. Use of IONM facilitates the surgical process and can reduce surgical risk by providing alerts to surgeons of potential harm to the spinal cord or neural structures. Under the Impulse Monitoring model, neurophysiologists located in the operating room work in partnership with supervising physicians who oversee the interpretation of neurophysiologic data gathered via real-time broadband transmission.

“This acquisition comes on the heels of our adding several major client facilities in the Syracuse area over the last 12 months,” said IMI President and CEO, Gene Cattarina. “Now, with Great Lakes, we have established a significant presence we can continue to develop in the important western New York region.” Cattarina stated that Great Lakes delivers its services via two main business models: outsourcing and in-service. The outsourced model is very similar to IMI’s approach, featuring real-time physician oversight of on-site neurophysiologists. For the in-service model GLIM provides the neuromonitoring oversight and infrastructure, while the hospital provides the technologists. Both delivery methods are highly compatible with IMI’s service model, which will allow a rapid integration of GLIM into the IMI organization.

“These similar methodologies, combined with IMI’s powerful and unique IT infrastructure, will allow us to smoothly leverage the synergies of this acquisition to quickly continue our aggressive growth strategy,” added Cattarina.

Ron Broome, CEO of Archer stated, “We are very pleased to know that our successful IOM business will be further enhanced by Impulse. This will allow Archer to focus on its other verticals including, video ambulatory EEG and ICU monitoring.”

About Impulse Monitoring

Impulse Monitoring, Inc. (IMI) provides surgical support services to hospitals and other facilities that include onsite and remote intraoperative neuromonitoring (IONM) for spinal, nerve and brain-related surgeries, and Autotransfusion (AT). IONM allows early detection of neurological compromise and identification of functional neural structures during surgery. IMI’s AT service captures and cleanses a patient’s own blood before and during surgery, making it available for transfusion instead of donated blood. Visit the IMI website at: www.imi.net



CONTACT:

Impulse Monitoring, Inc.
Rob Snow, 410-740-2370
[email protected]

KEYWORDS:   United States  North America  Maryland  New York

INDUSTRY KEYWORDS:   Surgery  Health  Hospitals  Medical Devices  Mental Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.